U.S. pharmaceutical industry

Detailed references
Editorially prepared
Download as PDF / PPT

Statista dossier about the U.S. pharmaceutical industry

This dossier presents graphs and tables about the U.S. pharmaceutical industry. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This document includes some of the most important key figures on U.S. revenues, top companies, top products, medicine use facts, research and development, and an outlook for the coming years.

1. Contribution to global pharma
- World pharmaceutical market distribution by submarket 2014-2018
- World pharmaceutical sales 2016-2018 by region
- Market share of the leading 10 global pharmaceutical markets 2017
- Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in life sciences sector M&As 2018
2. Overview
- U.S. total medicine spending 2002-2016
- Leading therapy areas for U.S. drug spending 2016
- U.S. top 20 prescribed drugs based on sales 2016
- Top U.S. pharma products by prescriptions 2016
- Pharmaceutical channel distribution by U.S. spending 2014-2016
- Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical export volume 2002-2017
3. Companies
- 2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue 2005-2018
- Pfizer's total revenue 2006-2018
- Merck & Co - total revenue 2006-2018
- Ad spending of pharmaceutical companies in the U.S. 2015
- Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top pharmaceutical companies located in Canada by revenue 2016
4. Research and development
- Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Pharmaceuticals: biopharma medicines in development 2018 by category
- Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the U.S. 2000-2014
- U.S. sales growth of new brand medicines 2011-2015
- R&D expenditure per employee in U.S. sectors 2000-2014
5. Generics
- Spending change on branded and generic medicines in the U.S. 2013-2017
- U.S. brand and generic prescription drug revenue 2005-2016
- Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the U.S. 2008-2017
- Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
6. Outlook
- Forecast of CAGR global pharmaceutical industry by region 2015-2018
- Global spending on medicines by regional share forecast 2020
- World pharmaceutical sales by region forecast 2022
- Top branded biologic drugs in the U.S. that will go generic by 2028
- Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
7. The consumer's view
- U.S. adults impression of the U.S. pharma industry
- U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- U.S. adults impression of the U.S. pharma drug qualities
- U.S. adults impression of the U.S. pharma companies fairness towards patients
- U.S. adults who would rate selected pharma features as excellent or good 2017
- Preferred pharma companies by Americans for drug purchase 2017
- Americans on US pharma quality compared to foreign pharma 2017

Order dossier

Dossier Details

U.S. pharmaceutical industry

Pages:	110
Document:	PPTX, PDF

Access after purchase:

Download from this page

Price

$365.00

More than 7,500
companies trust
Statista

Google

Samsung

Unilever

Procter and Gamble

Adobe

Telekom

PayPal

Otto

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron about Statista CEO, MindShare Germany